High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. - Test2 - elhamkhani - TriplyDB

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

http://www.wikidata.org/entity/Q40037737

about

Lack of heterologous cross-reactivity towards HLA-A*02:01 restricted viral epitopes is underpinned by distinct αβT cell receptor signatures The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection Protective immunity against hepatitis C: many shades of gray.Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.Effects of a couple-based intervention to reduce risks for HIV, HCV, and STIs among drug-involved heterosexual couples in Kazakhstan: a randomized controlled trial.Hepatitis C transmission and treatment in contact networks of people who inject drugs.Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence Anti-hepatitis C virus T-cell immunity in the context of multiple exposures to the virus.The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments.Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America.HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine Establishing the Melbourne Injecting Drug User Cohort Study (MIX): rationale, methods, and baseline and twelve-month follow-up results Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study.Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Opioids and HIV/HCV infection.The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.Australians living with and managing hepatitis C.Adaptive immunity to the hepatitis C virus.Identifying newly acquired cases of hepatitis C using surveillance: a literature review.The past, present and future of neutralizing antibodies for hepatitis C virus.Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

P2860

Q27728085-08EBC117-1FD7-412D-B4FC-357937C70903 Q28476680-5A63697F-705E-40F7-B77E-F171D96A0FE7 Q28477057-391EFAD5-5E4F-4C31-BB35-B8679A91BCD4 Q28478744-CCB5C4D6-A4EA-4DEC-B396-FB41C1C9A140 Q28484576-7B5D8A3E-972B-4852-9E63-ECE8A76EA0A6 Q28540278-689BB06D-4CDB-46C1-8460-3A9ED314AB35 Q30208996-8252871B-386C-4CEA-8F9A-1721ED2B84E1 Q30226978-493FEE4C-4BB7-42C8-95CA-F8F2B0CF0CED Q30884457-8DB74DFA-AE74-4011-80B2-6E04C9B749AE Q33650138-062A5577-FCC5-4EAD-9C0F-0622A2B69950 Q33759224-3175CE05-E9F1-4D6F-B891-E85D26998DBB Q33929089-5C5A3603-2A95-4372-8E46-4F84108F114A Q34173357-9C96D339-3E18-4A66-9E11-9806592CCFDC Q35040866-0339743D-6236-4156-80CF-A4230FE1F131 Q35540200-C06F8336-A8BC-4E91-9D65-662AF135312B Q35673342-8DB9C919-E82E-4758-8943-58A45C16EE9E Q35750560-37F3895D-F467-4C44-83A1-294060C94A0F Q35826504-E6A08C5F-BD60-4E7C-9575-C3670320D4A4 Q35846408-E8E6F461-9229-42E5-99EA-E7A0CADE9871 Q35883439-57EC1CDA-4D99-4152-A718-DE8FFB0EC9B6 Q36123263-14564CDC-8C2C-4ED1-AA8F-03D04025C07F Q36137527-0DC0550C-BC3E-4251-A981-A1BD8E182008 Q36148971-28161AC2-7760-4CD5-968B-1414647E8223 Q36482820-1B15233A-B771-446D-A2C0-6B9A04E8BE87 Q36506119-255FD661-5DBC-4739-A3D7-63DBE4EFF3B0 Q36517794-4406C731-A684-4BDB-8EFC-3D726E24F7C5 Q36698904-0282A04E-93CF-4926-90CE-C170AE122E48 Q36717008-34D6F062-6D22-4571-992C-735A2EC4602A Q36952990-ADDA3DC5-4F05-4CDA-8153-F9F1478730DD Q37040556-2683AB00-0A08-4337-860A-789CC625B63F Q37288631-92336AFA-0E57-4B65-B884-D5B323C5551F Q37460833-CEC20B47-02BE-4588-BFD2-063F0ADF0E16 Q37601315-13B074CC-E0E8-4C9E-9987-3FD0FF7298F7 Q37607856-C847F4EE-1F1C-470C-BCB8-5B5C94CEA6CE Q37717076-A005358B-1214-40DF-BB48-7B76FC7A457C Q37771936-0114C9F0-EC37-477A-B563-EA992C7EDE23 Q37805839-AF1616E4-C72A-4E87-897F-8B300DFC88BB Q38014990-58525C79-8103-4A65-8A83-24B8B1FD72E2 Q38192357-A9ADF0CF-CD2A-4E7A-83C8-73697ECBDB8F Q38381584-AD5EC8D8-EF2C-440E-9850-31CBEF4BAB70

P2860

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

http://www.wikidata.org/entity/Q40037737

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

@en

type

label

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

@en

prefLabel

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

@en

P1433

Q40037737-BF9AD505-E41D-428E-8B01-F9F78782AC1D

P1476

Q40037737-C7C828C7-A2EE-4569-82E3-BFC98C6A7B1D

P2093

Q40037737-15284CFE-5EC0-4913-BFBE-73B9EBCE5092

Q40037737-45E4D299-54BF-4D45-9C33-9F2E7C1EE65A

Q40037737-93EF2C58-A632-41B2-9F79-967494D1DD6D

Q40037737-C26995BD-425F-40FF-9F28-AA1354511C5D

Q40037737-D3281203-88C9-4D8F-94CB-7A354801E234

Q40037737-F5EC3F03-33B5-4612-A457-76E7A30EB320

P2860

Q40037737-0374E610-2862-47E7-B9C3-FFB208691D39

Q40037737-11A8D5BA-73BB-47D1-B067-FD198B500EC4

Q40037737-21D89E43-A72C-467B-9E60-F1D85DFA04DA

Q40037737-3DDBA0FE-DA3A-46B9-ABA1-B642DF89F47F

Q40037737-4DF09EAF-E25C-4047-B8A8-9B14B65104B9

Q40037737-5B65AC85-171B-4C20-9BF4-F015892317C4

Q40037737-643FB096-1E20-4779-B11D-60D2BBF96403

Q40037737-6CA08F08-3798-4736-9CA7-AF489A7D74CF

Q40037737-7D31391D-46A6-44CE-9B18-6BC1A324B9FC

Q40037737-86780F8A-AF1D-4F36-B3CD-9A99450FE528

P304

Q40037737-550A56D1-3FF3-415A-91B3-7DC0253B37ED

P31

Q40037737-CA96A132-8841-4C6F-8E98-CEF6D8AFBF95

P356

Q40037737-EB603C77-8BD2-4EEB-84DD-9AD8CE2F8327

P407

Q40037737-8FE37606-61B5-487D-A416-31D921CFF619

P433

Q40037737-984C08A3-F8AB-4AD5-8AA3-726428C6959A

P478

Q40037737-9108D973-DE6D-45E1-8003-37BBF80EA343

P50

Q40037737-99D749F6-A57B-4BDB-8205-FE54C6A3C88F

Q40037737-D0587257-A0B1-4C0E-B803-ECDB4C202BA8

P577

Q40037737-69E9C881-CBB8-4FF9-BE56-5AC09B95EC42

P5875

Q40037737-DBCF6B88-3970-448D-895E-9E390BC35A4F

P698

Q40037737-C680A888-1812-4647-BFD2-A14F4B0B8CED

P356

P1433

P1476

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

@en

P2093

David Scott Bowden

http://www.w3.org/2001/XMLSchema#string

Jennifer Lewis

http://www.w3.org/2001/XMLSchema#string

Mandvi Bharadwaj

http://www.w3.org/2001/XMLSchema#string

Margaret Hellard

http://www.w3.org/2001/XMLSchema#string

Samantha Lilly Tracy

http://www.w3.org/2001/XMLSchema#string

Timothy Spelman

http://www.w3.org/2001/XMLSchema#string

P2860

The evolution of human influenza viruses

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Global epidemiology of hepatitis C virus infection

Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Protection against persistence of hepatitis C.

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients.

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.

High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.

Correlates of lending needles/syringes among HIV-seropositive injection drug users.

Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.

P304

1746-1752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22534

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Heidi E Drummer

Campbell Aitken

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23308586

http://www.w3.org/2001/XMLSchema#string

P698

18844233

http://www.w3.org/2001/XMLSchema#string